ChAT-Expressing Neural Stem Cells for Alzheimer's Acetylcholine Restoration

Resolve Bottlenecks,
Find Innovative SolutionsGenerate Solutions

Solution Overview

Problem

Current therapies for Alzheimer's disease primarily focus on increasing acetylcholine levels through inhibiting acetylcholinesterase, offering only palliative relief and no protection against tissue destruction, necessitating a more effective approach to address cognitive disorders.

Innovation Solution

Human neural stem cells (NSCs) are transfected with a vector encoding human choline acetyltransferase (ChAT), allowing them to stably express ChAT, integrate into the brain, and differentiate into neurons, thereby restoring acetylcholine levels and cognitive functions.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Quantity of substance

If acetylcholinesterase inhibition is used to increase acetylcholine levels, then acetylcholine concentration is improved, but tissue destruction protection is not achieved

Engineering Contradiction:

Improveacetylcholine concentrationVSAvoidprotection against tissue destruction

Core Design Contradiction:

Quantity of substanceVSReliability

Solution Approach 1:

The patent introduces neural stem cells as intermediary carriers that can both produce acetylcholine and provide protective effects. These cells serve as a mediator between the need to increase acetylcholine levels and the need to protect against tissue destruction, combining multiple functions in a single therapeutic agent.

Inventive Principle:

Principle #24Intermediary (Mediator)

Solution Approach 2:

The patent creates a composite therapeutic system by combining neural stem cells with various functional genes (such as choline acetyltransferase, growth factors, and neuroprotective genes). This composite approach allows simultaneous achievement of acetylcholine production and tissue protection, resolving the contradiction between increasing acetylcholine and protecting against destruction.

Inventive Principle:

Principle #40Composite materials

2Ease of operation

If pharmaceutical therapy is used to increase acetylcholine, then cognitive function is temporarily improved, but no protection against progressive tissue destruction is provided

Engineering Contradiction:

Improvecognitive function improvementVSAvoidprotection duration

Core Design Contradiction:

Ease of operationVSDuration of action of stationary object

Solution Approach 1:

The patent applies preliminary action by transplanting neural stem cells before significant tissue destruction occurs. These cells are prepared in advance with protective and functional genes, allowing them to prevent and reverse damage while providing long-lasting protection, rather than merely treating symptoms after damage has occurred.

Inventive Principle:

Principle #10Preliminary action

Solution Approach 2:

The neural stem cells exhibit self-service capabilities by autonomously producing acetylcholine, secreting growth factors, and providing neuroprotective effects without requiring continuous external pharmaceutical intervention. This self-sustaining function enables long-duration protection and cognitive improvement.

Inventive Principle:

Principle #25Self-service

3Reliability

If stem cell transplantation is used to restore tissue, then tissue protection is achieved, but acetylcholine level restoration is not sufficient

Engineering Contradiction:

Improvetissue protectionVSAvoidacetylcholine level

Core Design Contradiction:

ReliabilityVSQuantity of substance

Solution Approach 1:

The patent makes the neural stem cells universal by introducing multiple functional genes into a single cell type. These cells simultaneously perform tissue protection, acetylcholine production, and cognitive function enhancement, eliminating the need for separate therapies for each function and ensuring both tissue protection and adequate acetylcholine restoration.

Inventive Principle:

Principle #6Universality (Multi-functionality)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The genetically modified NSCs effectively restore learning and memory functions in Alzheimer's disease models by elevating acetylcholine levels, providing a potential therapeutic solution for cognitive disorders beyond palliative relief.

Implementation Method 1

decreased activity of enzyme choline acetyltransferase (ChAT) responsible for acetylcholine (Ach) synthesis is observed

Methodology Applied

Scientific EffectCholine acetyltransferase catalysis: Enzyme

Data Source

PatentEP2626419B1Human neural stem cells expressing human choline acetyltransferase, and use thereof

Publication Date: 2016.11.09 CHUNGBUK NAT UNIV IND ACADEMIC COOPERATION FOUND

Figure 1A~1D
Figure 2A~2G
Figure 3A~3B

AI summary

The present invention relates to human neural stem cells (NSCs) transfected with a vector comprising a polynucleotide encoding human choline acetyltransferase (ChAT) and thereby stably expressing the human ChAT, a composition for treating Alzheimer disease or for improving a cognitive disorder comprising the human NSCs expressing a human ChAT. The present human NSCs genetically modified to express human ChAT, when transplanted into the brain of the animal AD model, successfully integrated into the host tissues and differentiated into the normal neuronal cells or glial cells. The instant genetically modified human NSCs stably express ChAT in the brain tissue of AD animal and thereby restore the acetylcholine level, and learning and memory function comparable to normal animal. The present genetically modified human NSCs expressing ChAT can be used for the treatment of AD as well as cognitive disorders due to other brain diseases and aging.